| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/16/2009 | CN100540050C Vaccine composition comprising interleukin-15 (IL-15) |
| 09/16/2009 | CN100540010C Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 09/15/2009 | US7589182 Capable of detecting and isolating polypeptides that are tyrosine-sulfated; specific for a sulfated tyrosine antigenic determinant in a sulfotyrosine-containing polypeptide |
| 09/15/2009 | US7589181 Humanized anti-TAG-72 CC49 monoclonal antibodies; retain binding affinity for TAG-72 and have reduced immunogenicity, as compared to a parental HuCC49V10 antibody; carcinoma; antitumor agent |
| 09/15/2009 | US7589180 Specific binding proteins and uses thereof |
| 09/15/2009 | US7589179 Modified interleukin-7 (IL-7) polypeptides with reduced T-cell response |
| 09/15/2009 | US7589174 GRP94-based compositions and methods of use thereof |
| 09/15/2009 | US7589172 PRO256 polypeptides |
| 09/15/2009 | US7589070 Surface modification for improving biocompatibility |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7588930 Fusing to the antigen a Listerial truncated ActA protein; listeria vaccine strain |
| 09/15/2009 | US7588920 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 09/15/2009 | US7588919 Polynucleotide encoding an IL-28B polypeptide |
| 09/15/2009 | US7588918 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 09/15/2009 | US7588912 Compositions and methods for preventing and treating anthrax diseases |
| 09/15/2009 | US7588774 Molecules enhancing dermal delivery of influenza vaccines |
| 09/15/2009 | US7588773 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell |
| 09/15/2009 | US7588772 adeno-associated viral capsid proteins are generated by gene expressing from a genetic engineered vector; high transduction efficiency and low level of neutralization by the human immune system |
| 09/15/2009 | US7588771 anticancer treatment by administering a recombinant vaccina virus of a modified TK thymidine kinase and HA hemagglutinin gene; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588770 Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins |
| 09/15/2009 | US7588769 Recombinant influenza virus comprising a mutant membrane protein gene, e.g., a mutant integral membrane protein gene such as a mutant type III integral membrane protein gene, which does not encode a functional membrane protein or a functional portion thereof; use in gene therapy |
| 09/15/2009 | US7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/15/2009 | US7588767 Recombinant vaccina virus of a modified TK and HA gene and optionally a modified F3 gene or locus; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588766 Treatment of amyloidogenic disease |
| 09/15/2009 | US7588765 Coupling a endotoxin (LPS) free polyfunctional polysaccharide with a polyfunctional carrier protein with quantitative yields; vaccine comprising a glycoconjugate antigen specific for Neisseria meningitidis |
| 09/15/2009 | US7588764 Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles |
| 09/15/2009 | US7588763 Methods for the prevention against or treatment of diabetes with ETXB and/or insulin |
| 09/15/2009 | US7588762 Streptoccal inhibitor of complement-mediated lysis, protein SIC |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | CA2616765C Control of parasitic infestations in farmed and wild fish |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2366514C Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 09/15/2009 | CA2270423C Prophylactic/therapeutic agent |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/14/2009 | CA2640954A1 Hepatitis c virus inhibitors |
| 09/11/2009 | WO2009111793A2 Subdermal tissue remodeling using myostatin, methods and related systems |
| 09/11/2009 | WO2009111691A2 Combination therapy with c-met and egfr antagonists |
| 09/11/2009 | WO2009111638A1 Compositions and methods for drug delivery |
| 09/11/2009 | WO2009111599A2 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/11/2009 | WO2009111529A2 Method of treating polycystic kidney disease |
| 09/11/2009 | WO2009111508A2 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/11/2009 | WO2009111507A1 Metalloproteinase 12 binding proteins |
| 09/11/2009 | WO2009111450A2 Metalloproteinase 9 binding proteins |
| 09/11/2009 | WO2009111444A1 Modulation of srpx2-mediated angiogenesis |
| 09/11/2009 | WO2009111315A2 Methods for reducing granulomatous inflammation |
| 09/11/2009 | WO2009111304A2 A fusion-intermediate state of hiv-1 gp41 targeted by broadly neutralizing antibodies |
| 09/11/2009 | WO2009111177A2 Compositions and methods comprising genetically enhanced obligate and facultative anaerobic bacteria for oncopathic cancer therapy |
| 09/11/2009 | WO2009110950A1 Attenuated listeria strain and adenovirus strain vaccines and methods of use |
| 09/11/2009 | WO2009110944A1 Modified toxins |
| 09/11/2009 | WO2009109911A1 Methods of treating chronic pain |
| 09/11/2009 | WO2009109908A1 Methods of treating inflammatory pain |
| 09/11/2009 | WO2009109860A2 Mutant forms of chlamydia htra |
| 09/11/2009 | WO2009109855A2 Immunotherapy for unresectable pancreatic cancer |
| 09/11/2009 | WO2009109643A2 Use of interleukin-1 conjugates in the treatment of diabetes |
| 09/11/2009 | WO2009109584A1 ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX |
| 09/11/2009 | WO2009109550A1 Process for stabilizing an adjuvant containing vaccine composition |
| 09/11/2009 | WO2009109428A2 Self-assembling peptide nanoparticles useful as vaccines |
| 09/11/2009 | WO2009109359A1 Protein or glycoprotein from haliotis midae and its use as an immunotherapy agent |
| 09/11/2009 | WO2009088849A3 Treatment or prevention of inflammation by targeting cyclin d1 |
| 09/11/2009 | WO2009088255A3 Method for preparing antigen effective for preventing anthrax infection |
| 09/11/2009 | WO2009055074A3 Erbb2 binding proteins and use thereof |
| 09/11/2009 | WO2008150308A3 Bcl-2 proteins for inhibiting cell death or inflammation in mammals |
| 09/11/2009 | WO2007066334A9 Improved influenza vaccine |
| 09/11/2009 | WO2007026190A9 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| 09/11/2009 | WO2006031870A9 Strain independent amplification of pathogens and vaccines thereto |
| 09/11/2009 | WO2004039952A3 Methods of use for novel human polypeptides encoded by polynucleotides |
| 09/11/2009 | CA2717803A1 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/11/2009 | CA2717736A1 Modulation of srpx2-mediated angiogenesis |
| 09/11/2009 | CA2717576A1 Metalloproteinase 9 binding proteins |
| 09/11/2009 | CA2717538A1 Metalloproteinase 12 binding proteins |
| 09/11/2009 | CA2717108A1 Use of interleukin-1 conjugates in the treatment of diabetes |
| 09/11/2009 | CA2716851A1 Combination therapy with c-met and egfr antagonists |
| 09/11/2009 | CA2716799A1 Methods of treating inflammatory pain |
| 09/11/2009 | CA2716424A1 Methods of treating chronic pain |
| 09/11/2009 | CA2716399A1 Process for stabilizing an adjuvant containing vaccine composition |
| 09/11/2009 | CA2713879A1 Self-assembling peptide nanoparticles useful as vaccines |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090228996 Means and Methods for influencing Interactions Between Dc-Sign and Dc-Sign Ligands |
| 09/10/2009 | US20090228994 Antibody Composition-Producing Cell |
| 09/10/2009 | US20090227776 Compositions and methods for the diagnosis and treatment of tumor |
| 09/10/2009 | US20090227770 Polypeptide carrier protein |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227658 Methods and compositions for immunization against hiv |
| 09/10/2009 | US20090227510 Induction of tumor immunity by variants of folate binding protein |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227468 Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes |
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/10/2009 | US20090227020 Immunogenic peptides |
| 09/10/2009 | US20090227014 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/10/2009 | US20090227012 Nucleotide sequences coding modified immunoglobulin for use in prevention and treatment of cancer and/or inflammatory disease |
| 09/10/2009 | US20090226930 Beta cell antigen |
| 09/10/2009 | US20090226893 Methods of studying tolerance in mhc-ii transgenic animals |
| 09/10/2009 | US20090226530 Powdered protein compositions and methods of making same |
| 09/10/2009 | US20090226520 Medical composition employing nanostructures |
| 09/10/2009 | US20090226508 Methods And Materials For Immunization Against Cancer |
| 09/10/2009 | US20090226490 Use of Whole Bacterial Cells (Actinomycetales) for Maternal Administration to Modulate Offspring Immune Response |
| 09/10/2009 | US20090226489 Viral vaccine composition, process and methods of use |